| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |